Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.

AIM To enumerate and characterize multipotential stromal cells (MSCs) in a cellular bone allograft and compare with fresh age-matched iliac crest bone and bone marrow (BM) aspirate. MATERIALS & METHODS MSC characterization used functional assays, confocal/scanning electron microscopy and whole-genome microarrays. Resident MSCs were enumerated by flow cytometry following enzymatic extraction. RESULTS Allograft material contained live osteocytes and proliferative bone-lining cells defined as MSCs by phenotypic and functional capacities. Without cultivation/expansion, the allograft displayed an 'osteoinductive' molecular signature and the presence of CD45(-)CD271(+)CD73(+)CD90(+)CD105(+) MSCs; with a purity over 100-fold that of iliac crest bone. In comparison with BM, MSC numbers enzymatically released from 1 g of cellular allograft were equivalent to approximately 45 ml of BM aspirate. CONCLUSION Cellular allograft bone represents a unique nonimmune material rich in MSCs and osteocytes. This osteoinductive graft represents an attractive alternative to autograft bone or composite/synthetic grafts in orthopedics and broader regenerative medicine settings.

[1]  K. Kaneko,et al.  Supercharging allografts with mesenchymal stem cells in the operating room during hip revision , 2014, International Orthopaedics.

[2]  C. Becker.  Sclerostin inhibition for osteoporosis--a new approach. , 2014, The New England journal of medicine.

[3]  P. Giannoudis,et al.  Native multipotential stromal cell colonization and graft expander potential of a bovine natural bone scaffold , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  P. Giannoudis,et al.  Induced periosteum a complex cellular scaffold for the treatment of large bone defects. , 2013, Bone.

[5]  K. Tarte,et al.  Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. , 2013, Cytotherapy.

[6]  P. Hernigou,et al.  Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells , 2013, International Orthopaedics.

[7]  Matthew D Ammerman,et al.  The role of Osteocel Plus as a fusion substrate in minimally invasive instrumented transforaminal lumbar interbody fusion , 2013, Clinical Neurology and Neurosurgery.

[8]  F. Mulero,et al.  Characterization of skeletal alterations in a model of prematurely aging mice , 2013, AGE.

[9]  H. Northoff,et al.  Mesenchymal stromal/stem cells markers in the human bone marrow. , 2013, Cytotherapy.

[10]  S. Melov,et al.  Single cell gene expression profiling of cortical osteoblast lineage cells. , 2013, Bone.

[11]  R. Jandial,et al.  Lineage mapping and characterization of the native progenitor population in cellular allograft. , 2013, The spine journal : official journal of the North American Spine Society.

[12]  R. Oreffo,et al.  Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration. , 2013, Cytotherapy.

[13]  G. Grabowski,et al.  Bone Graft and Bone Graft Substitutes in Spine Surgery: Current Concepts and Controversies , 2013, The Journal of the American Academy of Orthopaedic Surgeons.

[14]  A. Tohmeh,et al.  Allograft Cellular Bone Matrix in Extreme Lateral Interbody Fusion: Preliminary Radiographic and Clinical Outcomes , 2012, TheScientificWorldJournal.

[15]  A. Weeraratna,et al.  Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesis. , 2012, Experimental cell research.

[16]  E. Benzel,et al.  A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. , 2012, The spine journal : official journal of the North American Spine Society.

[17]  Cameron Howes,et al.  Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis , 2012, TheScientificWorldJournal.

[18]  P. Giannoudis,et al.  Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. , 2012, Arthritis and rheumatism.

[19]  P. Doevendans,et al.  Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation , 2012, Journal of cellular and molecular medicine.

[20]  P. Kloen,et al.  Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions. , 2012, Bone.

[21]  H. Qian,et al.  Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein* , 2012, The Journal of Biological Chemistry.

[22]  P. Giannoudis,et al.  Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. , 2012, Cytotherapy.

[23]  S. Hollawell.  Allograft cellular bone matrix as an alternative to autograft in hindfoot and ankle fusion procedures. , 2012, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[24]  P. Giannoudis,et al.  High abundance of CD271+ multipotential stromal cells (MSCs) in intramedullary cavities of long bones , 2012, Bone.

[25]  T. Yoshii,et al.  Hybrid Grafting Using Bone Marrow Aspirate Combined With Porous &bgr;-Tricalcium Phosphate and Trephine Bone for Lumbar Posterolateral Spinal Fusion: A Prospective, Comparative Study Versus Local Bone Grafting , 2012, Spine.

[26]  E. Guerado,et al.  What bone graft substitutes should we use in post-traumatic spinal fusion? , 2011, Injury.

[27]  H. Fischer,et al.  Scaffolds for bone healing: concepts, materials and evidence. , 2011, Injury.

[28]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[29]  Rozalia Dimitriou,et al.  Bone regeneration: current concepts and future directions , 2011, BMC medicine.

[30]  M. Ehinger,et al.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. , 2011, Blood.

[31]  B. Guillotin,et al.  Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling , 2011, Molecular biology of the cell.

[32]  B. McAllister.  Stem cell-containing allograft matrix enhances periodontal regeneration: case presentations. , 2011, The International journal of periodontics & restorative dentistry.

[33]  Hiromu Ito,et al.  Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources , 2011, Modern rheumatology.

[34]  M. Neo,et al.  A Bioactive and Bioresorbable Porous Cubic Composite Scaffold Loaded With Bone Marrow Aspirate: A Potential Alternative to Autogenous Bone Grafting , 2011, Spine.

[35]  Mario Roederer,et al.  Interpretation of cellular proliferation data: Avoid the panglossian , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  L. Bonewald,et al.  The Amazing Osteocyte , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  Jin Hwan Kim,et al.  Do the Adjacent Level Intervertebral Discs Degenerate After a Lumbar Spinal Fusion?: An Experimental Study Using a Rabbit Model , 2010, Spine.

[38]  R. Zernicke,et al.  In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. , 2010, Arthritis and rheumatism.

[39]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[40]  T. Albert,et al.  Graft Options in Posterolateral and Posterior Interbody Lumbar Fusion , 2010, Spine.

[41]  Daniel P Nicolella,et al.  Dendritic processes of osteocytes are mechanotransducers that induce the opening of hemichannels , 2010, Proceedings of the National Academy of Sciences.

[42]  C. Seebach,et al.  Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. , 2010, Injury.

[43]  P. Emery,et al.  Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. , 2010, Arthritis and rheumatism.

[44]  Jeffrey C. Wang,et al.  Bone Morphogenetic Protein-2 and Bone Marrow Aspirate With Allograft as Alternatives to Autograft in Instrumented Revision Posterolateral Lumbar Spinal Fusion: A Minimum Two-Year Follow-up Study , 2010, Spine.

[45]  B. Moed,et al.  Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice , 2010, Journal of anatomy.

[46]  Tzu-chin Wu,et al.  Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt Pathways , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  D. Rowe,et al.  Identification of differentially expressed genes between osteoblasts and osteocytes. , 2009, Bone.

[48]  A. Gonshor,et al.  Histologic evaluation of a stem cell-based sinus-augmentation procedure. , 2009, Journal of periodontology.

[49]  L. Ackerson,et al.  Mesenchymal stem cell allograft in revision foot and ankle surgery: a clinical and radiographic analysis. , 2009, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[50]  L. Kanz,et al.  Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1 , 2009, Haematologica.

[51]  P. Kasten,et al.  Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. , 2008, European cells & materials.

[52]  C. Choong,et al.  PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.

[53]  Y. Tokuhashi,et al.  Effects of Fibronectin on Osteoinductive Capability of Fresh Iliac Bone Marrow Aspirate in Posterolateral Spinal Fusion in Rabbits , 2008, Spine.

[54]  N. Boiret-Dupré,et al.  Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy , 2007, British journal of haematology.

[55]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[56]  I Harvey,et al.  Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. , 2007, Health technology assessment.

[57]  L. Kanz,et al.  Novel Markers for the Prospective Isolation of Human MSC , 2007, Annals of the New York Academy of Sciences.

[58]  O. Barbier,et al.  Bone allografts: What they can offer and what they cannot. , 2007, The Journal of bone and joint surgery. British volume.

[59]  H. Ouyang,et al.  The Immunogenicity and Immunomodulatory Function of Osteogenic Cells Differentiated from Mesenchymal Stem Cells , 2006, The Journal of Immunology.

[60]  P. Hernigou,et al.  The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. , 2005, The Journal of bone and joint surgery. British volume.

[61]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[62]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[63]  K. Kraus,et al.  Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. , 2003, The Journal of bone and joint surgery. American volume.

[64]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[65]  D. Soligo,et al.  Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. , 2002, Experimental hematology.

[66]  Christopher F. Hyer,et al.  Role of cellular allograft containing mesenchymal stem cells in high-risk foot and ankle reconstructions. , 2013, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[67]  M. Blanco-Gelaz,et al.  Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy. , 2013, Transplantation proceedings.

[68]  R. Oreffo,et al.  Tissue engineering strategies in spinal arthrodesis: the clinical imperative and challenges to clinical translation. , 2013, Regenerative medicine.

[69]  P. Nunley,et al.  The use of osteo-conductive stem-cells allograft in lumbar interbody fusion procedures: an alternative to recombinant human bone morphogenetic protein. , 2011, Journal of surgical orthopaedic advances.

[70]  A. Gonshor,et al.  Histologic and histomorphometric evaluation of an allograft stem cell-based matrix sinus augmentation procedure. , 2011, The International journal of oral & maxillofacial implants.

[71]  B. Ziran,et al.  Use of solid and cancellous autologous bone graft for fractures and nonunions. , 2010, The Orthopedic clinics of North America.

[72]  T. Brosky,et al.  Reconstruction of the first metatarsophalangeal joint following post-cheilectomy avascular necrosis of the first metatarsal head: a case report. , 2009, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[73]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[74]  坂口 祐輔.  Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates , 2005 .